跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
vitamin K-based
首页
药物
vitamin K-based
vitamin K-based
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Vitamin-targeted imaging agents
US 7128893 B2
申请人: ENDOCYTE INC
优先权: 2002
US
WO
9 件公开
Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
US 7635692 B2
申请人: DSM IP ASSETS BV
优先权: 2001
EP
US
4 件公开
COMBINATION OF VITAMIN K AND VITAMIN K ANTAGONIST SUCH AS R-ISOMER OF WARFARIN, PHENPROCOUMON OR R-ISOMER OF PHENPROCOUMON AS ANTICOAGULANT THERAPY
US 2010034878 A1
申请人: BUSSEY HENRY I
优先权: 2006
US
WO
2 件公开
QUICK-DRYING COSMETIC EMULSIONS FOR ROLL-ON APPLICATION
EP 2023888 B1
申请人: HENKEL AG & CO KGAA
优先权: 2007
EP
Zeolite Formulation And Use Thereof For The Prevention And Therapy Of Diseases Caused By Infections With Herpes Simplex Virus Type 1 And Type 2
US 2011081405 A1
申请人: MIKLOSKA ZORKA
优先权: 2008
US
Scalable vitamin composition unit dosage for the treatment of fat-soluble vitamin deficiencies
US 10688107 B2
申请人: CALLION PHARMA LLC
优先权: 2016
US
Plant-based qi-regulating skin moisturizer
CN 109419660 A
申请人: SHANTOU JINGZHAN FINANCIAL CONSULTING CO LTD
优先权: 2017
CN
Compound orlistat nanoemulsion and preparation method thereof
CN 107744537 A
申请人: CHENGDU LINGXI SHANGPIN TECH CO LTD
优先权: 2017
CN
Vitamin K epoxy reductase compound subunit 1 mutant protein and applications thereof
CN 108546689 A
申请人: TIANJIN HUBIN PANGU GENE SCIENCE DEV CO LTD
优先权: 2018
CN
Method of treating late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency by individually tailored glucocorticoid regimen
US 11951112 B2
申请人: MASIUTIN MAXIM
优先权: 2021
US
第 1 / 2 页
上一页
下一页
药物
反馈